Daniel W. Wagner

Senior Managing Director at Connecticut InnovationsBoard of Directors

Dan Wagner is currently the Senior Managing Director of Investments at Connecticut Innovations (CI). He is responsible for evaluating investment opportunities, structuring investments and monitoring portfolio companies through active board participation. Dan has led or assisted with CI’s investments in AxioMx (acquired by Abcam); Affomix (acquired by Illumina); CyVek (acquired by Bio-Techne); Cara Therapeutics (NASDAQ: CARA); HistoRx (acquired by Genoptix); Melinta Therapeutics, formerly Rib-X (NASDAQ: MLNT); RemoteReality (acquired by RTI); Biohaven Pharmaceuticals (NYSE:  BHVN); and Arvinas (NASDAQ: ARVN).